Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 66.85%5.32B | ---- | 3.80%8.69B | ---- | -38.28%3.19B | ---- | -11.62%8.37B | ---- | -5.81%5.17B |
| Profit adjustment | ||||||||||
| Interest expense - adjustment | ---- | 12.44%2.34B | ---- | ---- | ---- | 6.47%2.08B | ---- | ---- | ---- | 0.36%1.95B |
| Dividend (income)- adjustment | ---- | -21.31%-1.36B | ---- | 9.00%-2.2B | ---- | 8.63%-1.12B | ---- | -28.42%-2.42B | ---- | -45.64%-1.23B |
| Attributable subsidiary (profit) loss | ---- | 73.28%-1.66M | ---- | -12.82%-8.32M | ---- | -5,660.19%-6.22M | ---- | 45.45%-7.37M | ---- | 98.50%-108K |
| Impairment and provisions: | ---- | -2.44%97.88M | ---- | 189.55%109.18M | ---- | 804.31%100.33M | ---- | -139.23%-121.93M | ---- | -116.35%-14.25M |
| -Other impairments and provisions | ---- | -2.44%97.88M | ---- | 189.55%109.18M | ---- | 804.31%100.33M | ---- | -139.23%-121.93M | ---- | -116.35%-14.25M |
| Revaluation surplus: | ---- | 100.54%6.91M | ---- | 93.92%-135.52M | ---- | 33.79%-1.28B | ---- | -251.15%-2.23B | ---- | -4,043.64%-1.94B |
| -Other fair value changes | ---- | 100.54%6.91M | ---- | 93.92%-135.52M | ---- | 33.79%-1.28B | ---- | -251.15%-2.23B | ---- | -4,043.64%-1.94B |
| Asset sale loss (gain): | ---- | -17.83%-225.36M | ---- | -10.01%-405.38M | ---- | -65.11%-191.26M | ---- | -95.49%-368.48M | ---- | -3.28%-115.84M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -270.64%-831K | ---- | 92.09%-159K | ---- | 342.29%487K | ---- | -230.79%-2.01M | ---- | 47.79%-201K |
| -Loss (gain) from selling other assets | ---- | -17.10%-224.53M | ---- | -10.57%-405.22M | ---- | -65.81%-191.75M | ---- | -86.24%-366.47M | ---- | -3.46%-115.64M |
| Depreciation and amortization: | ---- | -1.41%619.8M | ---- | 10.19%1.25B | ---- | 15.28%628.65M | ---- | 12.30%1.14B | ---- | 11.66%545.31M |
| -Depreciation | ---- | -1.41%619.8M | ---- | 10.19%1.25B | ---- | 15.28%628.65M | ---- | 12.30%1.14B | ---- | 11.66%545.31M |
| Exchange Loss (gain) | ---- | -777.29%-49.45M | ---- | -564.02%-38.75M | ---- | 87.12%-5.64M | ---- | -68.01%8.35M | ---- | -302.57%-43.78M |
| Special items | ---- | ---- | ---- | 7.64%4.31B | ---- | ---- | ---- | 7.24%4.01B | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 99.20%6.75B | ---- | 38.16%11.58B | ---- | -21.66%3.39B | ---- | -39.92%8.38B | ---- | -38.13%4.32B |
| Change of operating capital | ||||||||||
| Financial assets at fair value (increase)decrease | ---- | 22.72%7.22B | ---- | 157.12%14.81B | ---- | 140.50%5.88B | ---- | 12.07%-25.93B | ---- | -278.37%-14.52B |
| Financial liabilities at fair value (increase)decrease | ---- | 63.13%-597.4M | ---- | 4.22%-1.93B | ---- | -136.54%-1.62B | ---- | -135.42%-2.02B | ---- | -12.98%4.43B |
| Buy and sell back financial assets (increase) decrease | ---- | 160.19%5.5B | ---- | -74.62%2.94B | ---- | -37.49%-9.13B | ---- | 280.96%11.6B | ---- | -214.39%-6.64B |
| Special items for working capital changes | ---- | 458.44%27.29B | ---- | -3,262.07%-24.98B | ---- | -53.38%4.89B | ---- | -101.73%-743.07M | ---- | 257.90%10.48B |
| Cash from business operations | ---- | 1,255.07%46.15B | ---- | 127.72%2.41B | ---- | 276.89%3.41B | ---- | -132.49%-8.71B | ---- | -116.78%-1.93B |
| Other taxs | ---- | -41.35%-1.1B | ---- | 4.73%-1.35B | ---- | 45.94%-780.79M | ---- | 44.07%-1.42B | ---- | 10.84%-1.44B |
| Adjustment items of business operations | 218.95%57.95B | ---- | 3,523.34%20.93B | ---- | 517.32%18.17B | ---- | 106.14%577.63M | ---- | -116.87%-4.35B | ---- |
| Net cash from operations | 218.95%57.95B | 1,616.09%45.05B | 3,523.34%20.93B | 110.52%1.06B | 517.32%18.17B | 177.90%2.62B | 106.14%577.63M | -141.71%-10.13B | -116.87%-4.35B | -134.19%-3.37B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 31.71%261.05K | ---- | ---- | ---- | -27.93%198.19K | ---- | ---- | ---- | -96.84%274.99K | ---- |
| Purchase of fixed assets | 7.15%-218.42M | 1.48%-130.79M | 23.63%-39.84M | 50.00%-538.84M | 12.64%-235.24M | 1.76%-132.75M | 19.86%-52.16M | -97.05%-1.08B | 1.24%-269.27M | -22.61%-135.13M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | --2.3B | ---- | --4.37B | ---- | ---- | ---- |
| Cash on investment | ---40.75B | -2,150.43%-34.74B | ---21.92B | -257.14%-15.16B | ---- | 126.32%1.69B | ---- | 80.92%-4.25B | 85.12%-1.81B | 7.20%-6.44B |
| Other items in the investment business | 411.77%1.87M | -20.73%914.51M | 274.21%654.62K | -10.79%2.38B | 7.40%366.24K | -20.76%1.15B | 18.06%174.93K | 28,488.13%2.67B | -43.85%340.99K | 70.65%1.46B |
| Net cash from investment operations | -2,085.14%-40.96B | -1,350.65%-33.96B | -608.42%-21.96B | -401.87%-13.32B | 199.31%2.06B | 153.07%2.72B | 343.35%4.32B | 87.50%-2.65B | 83.27%-2.08B | 17.40%-5.12B |
| Net cash before financing | -16.04%16.99B | 107.62%11.09B | -120.96%-1.03B | 4.10%-12.26B | 414.58%20.23B | 162.93%5.34B | 143.77%4.9B | -520.83%-12.78B | -148.02%-6.43B | -331.71%-8.49B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 178.00%43.87B | 217.39%23.82B | 469.62%15.2B | 225.53%27.6B | 114.14%15.78B | 29.42%7.51B | -30.09%2.67B | -3.64%8.48B | 23.99%7.37B | 98.62%5.8B |
| Refund | -64.39%-99.61B | ---- | -4.46%-25.47B | ---- | 9.63%-60.6B | ---- | -5.74%-24.38B | ---- | 14.37%-67.06B | ---- |
| Issuance of bonds | 61.39%73.75B | -19.05%32.95B | -3.60%15.82B | -0.64%98.28B | -33.18%45.7B | -12.50%40.71B | -39.26%16.41B | 0.12%98.91B | 4.08%68.39B | 13.43%46.53B |
| Interest paid - financing | ---- | -3.29%-1.62B | ---- | -5.38%-4.28B | ---- | 19.93%-1.57B | ---- | -5.64%-4.06B | ---- | -1.89%-1.96B |
| Dividends paid - financing | 9.97%-4.91B | -20.95%-852.21M | -14.86%-1.47B | -25.93%-2.64B | 8.41%-5.45B | ---704.6M | 21.72%-1.28B | 31.65%-2.09B | 8.22%-5.95B | ---- |
| Absorb investment income | 30.00%9.1B | ---- | -53.33%2.1B | ---- | --7B | ---- | --4.5B | ---- | ---- | ---- |
| Other items of the financing business | 0.01%-5.51B | -33.57%-62.08B | -3,115.44%-5.18B | -6.58%-96.34B | -885.02%-5.51B | -7.90%-46.48B | 17.30%-161.09M | 10.10%-90.4B | 20.03%-559.7M | 18.23%-43.07B |
| Net cash from financing operations | 641.68%16.69B | -1,342.88%-7.78B | 144.42%997.83M | 108.73%22.63B | -240.51%-3.08B | -107.40%-538.99M | -137.81%-2.25B | 7,940.64%10.84B | 157.08%2.19B | 168.31%7.29B |
| Effect of rate | 73.03%-182.59M | 50.16%-113.18M | -86.21%35.71M | -24.38%-685.17M | -61.52%-677.05M | 12.66%-227.08M | 162.97%258.95M | -458.53%-550.88M | -295.28%-419.17M | -252.21%-260M |
| Net Cash | 96.33%33.68B | -31.05%3.31B | -101.08%-28.61M | 633.93%10.37B | 504.61%17.15B | 500.58%4.8B | 150.51%2.65B | -161.22%-1.94B | -144.38%-4.24B | 82.89%-1.2B |
| Begining period cash | 29.35%167.98B | 26.85%45.75B | 29.35%167.98B | -6.46%36.07B | -8.73%129.86B | -6.46%36.07B | -8.73%129.86B | 9.44%38.56B | 15.45%142.28B | 9.44%38.56B |
| Cash at the end | 37.68%201.47B | 20.44%48.95B | 26.53%167.98B | 26.85%45.75B | 6.33%146.33B | 9.54%40.64B | -2.82%132.77B | -6.46%36.07B | 3.47%137.62B | 30.64%37.1B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.